Literature DB >> 6759403

Immune responses to Candida albicans in genetically distinct mice.

R F Hector, J E Domer, E W Carrow.   

Abstract

Mice from six genetically distinct strains were examined for their immune responses to Candida albicans in in vitro and in vivo assays, and naive mice and mice immunized with the fungus were challenged intravenously with three different doses of C. albicans to determine differences in susceptibility. Naive mice from the six groups showed substantial differences in resistance to challenge based on mortalities and quantitative cultures of kidneys, with mice from strains C57BL/6J and BALB/cByJ showing the most resistance; mice from strains A/J, C3H/HeJ, and CBA/J showing moderate susceptibility; and mice from strain DBA/2J showing the highest degree of susceptibility to challenge. Unimmunized mice from strains C57BL/6J and BALB/cByJ did not produce detectable levels of Candida-specific antibody by the end of the 28-day observation period when challenged intravenously, but the other strains did. Immunized mice showed a degree of protection to challenge, with all groups except mice from strain BALB/cByJ showing a reduction of two to three log units in the level of colonization in their kidneys and all strains producing significant levels of antibody. Additionally, the immunized mice of all strains developed substantial levels of delayed-type hypersensitivity and demonstrated nearly identical lymphocyte proliferative responses to Candida antigens. The results indicate that resistance to systemic candidiasis is dependent upon a combination of innate factors, predominately an intact complement system, and the acquisition of an immune response, most likely of a cell-mediated type. Additionally, the findings suggest that genetic control of acquired resistance to C. albicans may not be associated with the H-2 complex.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6759403      PMCID: PMC347851          DOI: 10.1128/iai.38.3.1020-1028.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

2.  Disseminated candidiasis in a previously healthy girl: implication of a leukocyte candidacidal defect.

Authors:  P J Staples; J Boujak; R G Douglas; J P Leddy
Journal:  Clin Immunol Immunopathol       Date:  1977-03

3.  Disseminated candidosis in cyclophosphamide induced leucopenic state: an experimental study.

Authors:  A K Mukherji; K C Mallick
Journal:  Indian J Med Res       Date:  1972-11       Impact factor: 2.375

4.  Passive immunization of mice against Candida albicans.

Authors:  S Mourad; L Friedman
Journal:  Sabouraudia       Date:  1968-02

5.  Experimental murine candidiasis: pathological and immune responses in T-lymphocyte-depleted mice.

Authors:  D K Giger; J E Domer; S A Moser; J T McQuitty
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

6.  Trypanosoma cruzi: correlation of resistance and susceptibility in infected bred mice with the in vivo primary antibody response to sheep red blood cells.

Authors:  H B Tanowitz; N Minato; R Lalonde; M Wittner
Journal:  Exp Parasitol       Date:  1981-10       Impact factor: 2.011

7.  Protective effect of glucan in experimentally induced candidiasis.

Authors:  D L Williams; J A Cook; E O Hoffmann; N R Di Luzio
Journal:  J Reticuloendothel Soc       Date:  1978-06

8.  Experimental murine candidiasis: pathological and immune responses to cutaneous inoculation with Candida albicans.

Authors:  D K Giger; J E Domer; J T McQuitty
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

9.  Role of complement during experimental Candida infection in mice.

Authors:  R Morelli; L T Rosenberg
Journal:  Infect Immun       Date:  1971-04       Impact factor: 3.441

10.  DISTRIBUTION, INHERITANCE, AND PROPERTIES OF AN ANTIGEN, MUB1, AND ITS RELATION TO HEMOLYTIC COMPLEMENT.

Authors:  B CINADER; S DUBISKI; A C WARDLAW
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

View more
  44 in total

1.  Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice.

Authors:  Mason X Zhang; M Charlotte Bohlman; Carol Itatani; Dennis R Burton; Paul W H I Parren; Stephen C St Jeor; Thomas R Kozel
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

2.  Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI.

Authors:  J E Domer; R E Garner; R N Befidi-Mengue
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

3.  Role of nitrogen and carbon transport, regulation, and metabolism genes for Saccharomyces cerevisiae survival in vivo.

Authors:  Joanne M Kingsbury; Alan L Goldstein; John H McCusker
Journal:  Eukaryot Cell       Date:  2006-05

4.  Virulence of the fungal pathogen Candida albicans requires the five isoforms of protein mannosyltransferases.

Authors:  Mahmoud Rouabhia; Martin Schaller; Cristina Corbucci; Anna Vecchiarelli; Stephan K-H Prill; Luc Giasson; Joachim F Ernst
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain.

Authors:  Alaka Mullick; Miria Elias; Serge Picard; Lucie Bourget; Orce Jovcevski; Susan Gauthier; Ashleigh Tuite; Penelope Harakidas; Craig Bihun; Bernard Massie; Philippe Gros
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 6.  IL-12 and related cytokines: function and regulatory implications in Candida albicans infection.

Authors:  Robert B Ashman; Dipti Vijayan; Christine A Wells
Journal:  Clin Dev Immunol       Date:  2010-11-01

7.  Effects of systemic cell-mediated immunity on vaginal candidiasis in mice resistant and susceptible to Candida albicans infections.

Authors:  P L Fidel; J L Cutright; J D Sobel
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

8.  Inoculation candidiasis in a murine model of severe combined immunodeficiency syndrome.

Authors:  S Mahanty; R A Greenfield; W A Joyce; P W Kincade
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

9.  Natural killer cells do not play a dominant role in CD4+ subset differentiation in Candida albicans-infected mice.

Authors:  L Romani; A Mencacci; E Cenci; R Spaccapelo; E Schiaffella; L Tonnetti; P Puccetti; F Bistoni
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

10.  Enhanced immune responses in mice treated with penicillin-tetracycline or trimethoprim-sulfamethoxazole when colonized intragastrically with Candida albicans.

Authors:  J E Domer; R F Hector
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.